Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetesMohammad Alhadj Ali, Colin Dayan, Hina Shariff et al.|Science Translational Medicine|2017Cited by 215
The efficacy and safety of ustekinumab in adolescents newly diagnosed with type 1 diabetes: the USTEK1D RCTKymberley Carter, Colin Dayan, WY Cheung et al.|Efficacy and Mechanism Evaluation|2025Cited by 2